1. Stillbirths are defined as 20 weeks gestation or
more; what about babies less than twenty weeks
gestation -- should they be evaluated?
The studies we recommend are those most helpful in
determining cause of intrauterine death based upon
experiences (from the literature and our own) with
infants who die at 20 or more weeks gestation. Yield from
many of these same investigations will probably be lower
in babies of shorter gestation. Nevertheless, certain of
those evaluations remain appropriate in fetuses younger
than 20 weeks gestation. We have generated a suggested
protocol for this circumstance that can be found in WiSSPers, vol. 2, no. 4,
p. 2. [WiSSP affiliates see Additional
Comments on Frequently Asked Questions.] 2.
What about liveborn babies dying in the first 24
hours who have malformations -- should they be
similarly evaluated?
Although the intent of WiSSP is the evaluation of
stillborns, the same diagnostic tools seem quite helpful
in evaluating early neonatal deaths under two
circumstances: in infants with obvious malformations; in
infants for whom there is no other reasonable clinical
cause of death evident (such as extreme prematurity,
respiratory distress syndrome etc.). [WiSSP affiliates
see Additional Comments on
Frequently Asked Questions.]
3. How harmful are delays in proceeding with
the protocol after the delivery of a stillborn?
Short delays (such as those to allow viewing or holding
of the infant by the parents) will not interfere
with appropriate evaluation. In fact, most of the
evaluations can be delayed if necessary for up to
24 hours if the baby's body is kept cooled (I.e. in the
morgue) and no embalming or fixation is performed during
this time. Time is most crucial in obtaining samples for
chromosomal study. For this, the longer the delay the
less likely will living cells be obtained. Samples should
be taken as soon as possible and preferably within a
couple of hours after delivery; and they should be
shipped to the cytogenetics laboratory as soon as
possible since shipment delays also are correlated with
growth failure.
4. What special problems should be anticipated when
babies are stillborn over a weekend?
The major difficulties usually are related to delays,
decisions about shipment of samples and unavailability of
key individuals. As noted in questions 3 delays of up to
24 hours prior to photographs, x-ray evaluation and post
mortem examination are acceptable if unavoidable.
However, someone must be available who can takes tissue
samples (other than those to be obtained at the time of
autopsy). Tissues can be left in tissue culture medium at
room temperature or refrigerated but not frozen
until shipped on Monday morning. While not optimal, such
delays in shipment are inevitable. [WiSSP affiliates see Additional Comments on Frequently
Asked Questions.]
5. What if parents decline autopsy of
their baby -- what then can be done?
Virtually everything else can be accomplished with formal
post mortem. While certain things will be missed (most
frequently 'silent' malformations such as kidney and hear
abnormalities), many diagnoses crucial in subsequent
counseling of families can be established with formal
autopsy. Clinical examination, photographs, x-rays and
cytogenetic testing will often yield information
sufficient to make a specific diagnosis. Methods for
obtaining samples for cytogenetic studies under these
circumstances are summarized in the section of the
protocol dealing with Sampling
for Chromosomal Evaluation. Obviously, placental
examination should also be completed even if an autopsy
is declined.
6. Is it really worthwhile to take samples for
chromosome studies in markedly macerated infants?
Yield is less. In infants evaluated through WiSSP about
60% of samples from babies with no, slight or mild
maceration were successfully grown, while only about 35%
of those babies with moderate or advanced maceration
yielded viable cells. Certain publications
notwithstanding, one cannot predict success or
failure of cultures on the basis of external macerative
criteria. The effort to obtain tissue samples in
macerated stillborns is worth it since it is just those
babies in whom external stigmata of chromosomal
abnormalities may be masked.
It is particularly important to sample fetal
placenta under those circumstances since these cells tend
to survive longer after fetal death. (See Placental and Cord Examination.)
7. What if tissue culture medium is
unavailable?
Samples for chromosomal analysis can still be taken. We
suggest drawing maternal blood in a sterile tube,
spinning it down and using the plasma or serum as
transport medium for the fetal tissue samples. Studies
suggest that this is considerably more successful than
the use of sterile saline. If maternal serum can not be
obtained, one can use sterile saline for shipment.
8. What if only parts of the protocol can be
completed -- is it still worthwhile?
Yes. Of course, the less that is done in evaluating a
baby, the less the likelihood that specific answers will
be found. [WiSSP affiliates see Additional
Comments on Frequently Asked Questions.]
9. Who interprets the results of the
evaluations?
With respect to fetal causes of stillbirth, it is usually
a clinical geneticist or dysmorphologist (see Access to Genetic Counseling
Services) who will be best able to interpret the
results of the investigations completed. Sometimes it
will be a perinatologist or obstetrician who has
developed special interest in the diagnostic assessment
of stillborns. It is wise for any institution
establishing a stillbirth assessment program to
antecedently identify who will be responsible for
reviewing all of the information and rendering a
diagnostic opinion. [WiSSP affiliates see Additional Comments on Frequently
Asked Questions.]
10. How long before results and interpretations are
available?
For WiSSP the average time between birth of a stillborn
infant and completion of a summary letter to the
attending physician has been about 3 months. This delay
is primarily the result of inevitable delays in receiving
the final autopsy dictation and/or the time necessary to
successfully grow cells and perform cytogenetic
evaluation. Parents should be made aware of this
inevitable delay in providing final results to them.
11. How should parents be informed
about the results of evaluation?
All families should receive at least a written summary of
the results of assessment. It is far better if they are
counseled in person. Some attending physicians will
prefer to counsel the parents themselves. Different
institutions may have individuals of varying backgrounds
(e.g. obstetrician, pathologist, genetics counselor,
nurse practitioner etc.) who have developed special
expertise to whom families can be referred. Alternatively
the parents can be referred for consultation through a
clinical genetics service (see Access
to Genetic Counseling Services). Referral for
genetics consultation is particularly appropriate when
malformations have been identified in the baby and in
those circumstances in which additional extensive family
evaluation seems warranted. [WiSSP affiliates see Additional Comments on Frequently
Asked Questions.]
12. How often will a specific cause of death be
found?
In the WiSSP series, about 40% of evaluations allowed
reasonable certainty in ascribing a specific cause of
death. This is comparable to other, hospital based series
in the literature (if a hodge-podge of
non-specific categories such as 'hypoxia' and
'prematurity' are not included as really indicative of
the cause of death). Of these, a majority are fetal
causes -- birth defects, malformational syndromes etc.,
while fewer are secondary to placental, cord, maternal or
environmental problems.
13. How much will all of this cost?
Different approaches can be made to estimating cost. This is more
fully discussed in WiSSPers, vol. 4, no. 1,.
If one considers real costs (in contrast to customary charges),
then a reasonable estimate of costs includes:
| Clinical Examination |
$ 10 |
| Photographs |
$ 9 |
| Radiography |
$ 40 |
| Internal Postmortem |
$490 |
| Cytogenetics |
$300 |
| Kleihauer-Betke |
$ 40 |
| Review and Interpretation |
$ 82 |
| Counseling |
$ 85 |
| TOTAL PER STILLBIRTH |
$956 |
14. Who pays for these evaluations?
Different institutions and different health care delivery
structures will have different answers to this questions.
In a fee for service setting, third party payers will
often cover all of the evaluations if they are
billed to the mother's hospital stay. Coverage for
postmortem charges are more likely if they are billed as
'comprehensive evaluation of products of conception' or
similar (since the stillborn has no legal standing and no
coverage).
In a managed care structure, efforts will have to
antecedently be made to assure that such evaluations are
viewed as essential and routine. The added cost to insure
that every stillbirth is assessed would be about $8.00
per normal delivery. This translates into only about 11¢
per covered life per year.
In those with no insurance or who are underinsured and
who are not covered by a managed care program, much of
the assessment can be completed without cost to the
parents if the birthing hospital is willing to 'forgive'
the costs of the evaluations as a good will gesture. In
addition, some University-affiliated cytogenetics
laboratories will forgive those costs not covered by
insurance so long as arrangements are made beforehand.
[WiSSP affiliates see Additional
Comments on Frequently Asked Questions.]
15. Is there information and support available
for parents?
Many hospitals have parent support groups, bereavement
counseling and/or individuals with particular interest in
providing emotional help for parents. Referral to local
resources can be made through national Support Organizations. (A list of
Wisconsin Support Groups
is included in this Web site as well).
16. Is there any source for resource materials
and literature appropriate for parents?
See the WiSSP Resource Library
on this web site. Each issue of WiSSPers
includes review of selected resources. Materials directly
available from WiSSP are listed on the Order Form of this web site.
17. What about scientific literature and
resources for health care professionals?
Each issue of WiSSPers
includes critical reviews of recent scientific
publications concerning stillbirth. In addition, the Citations to Recent Literature
section of this web site lists relevant resources
(updated quarterly) from the medical literature.
Materials directly available from WiSSP are listed on the
Order Form of this web
site.
18. We want to begin to offer stillbirth evaluations
in our institution. But we are not part of the WiSSP
network. How do we begin?
It takes time and lots of effort, but it is worth it
if you succeed in helping parents who have experienced a
stillbirth.
Education of the staff of the institution is a
critical first step. All relevant parties -- delivering
physicians, pathologists, obstetrical unit nurses,
bereavement personnel and administrators -- need to be
made aware of the importance of such evaluation (see list
of educational materials that might help on our Order Form). In many
hospitals, establishing an assessment program will
require the official endorsement of some hospital
committee (e.g. obstetrical committee). Key individuals
willing to act as resource persons need then to be
identified. Decisions will need to be made about
protocols to use; obviously we think the Protocol included in this
web site are appropriate models of those that any
birthing hospital can use. Who does what will also have
to be formalized -- i.e. who takes the pictures and with
what camera, who carries out external clinical
evaluation, who takes tissue samples, how do radiographs
get taken, which pathologist is used, which cytogenetics
laboratory should receive samples etc. These details will
differ for every birthing hospital.
Perhaps most challenging, some physician with expertise (or a willingness
to develop it) must be identified as the referent physician for assessment
and interpretation of all the studies once they are completed. More
nascent programs have failed because of the absence of such a person
than for any other. By prior arrangement WiSSP is willing to provide
consultation to programs regarding particularly problematic
or difficult to interpret outcomes of evaluations. Inquiries concerning
such consultation should be made by e-mail (modaff@waisman.wisc.edu)
or by postal mail (Wisconsin Stillbirth Service Program, Clinical
Genetics Center, University of Wisconsin-Madison, 1500 Highland Avenue
#343, Madison, WI 53705).
19. But we don't have a
"But we don't have a pediatric pathologist,
or a pediatric radiologist, or a geneticist, or a
genetics counselor, or an obstetrical nurse practitioner,
or a bereavement program, or a camera, or a billing
mechanism, or a sympathetic administration
or
whatever." Commitment, organization and
improvisation will work regardless of the hurdles. Someone
has to begin the process.
20. HELP!
If all else fails and you really need help contact us by e-mail (modaff@waisman.wisc.edu)
or by postal mail (Wisconsin Stillbirth Service Program, Clinical
Genetics Center, University of Wisconsin-Madison, 1500 Highland Avenue
#343, Madison, WI 53705). We will try to respond to all relevant professional
inquiries. (WiSSP affiliated institutions can find a list of telephone
numbers in the "Twenty Questions Most Often Asked about Stillbirth
Evaluation" section, question #20 of the protocol packets at
your institution).
< == Protocol
Guide to the Etiologic
Evaluation of the Stillborn
WiSSP home page
|